Related Article
- COVID-19: India reports 14,313 new cases, lowest in 244 days
- CM Yogi releases IIT Kanpur’s study on UP govt's handling of COVID which speaks about apt dealing
- COVID-19: India’s recovery rate touches 98 % for first time
- Brazilian President Jair Bolsonaro denied entry to football match for not having COVID-19 vaccination certificate
- India logs 18,166 Covid cases, 214 deaths in past 24 hours
Covaxin gets DCGI's nod for use in children above 2 years
New Delhi: Bharat Biotech's Covid-19 vaccine Covaxin secured approval from the Drugs Controller General of India (DCGI) on Tuesday for use on children above 2 years of age in a major boost to the country's fight against the pandemic.
Covaxin will be the first Covid-19 vaccine in the country to be administered to those below 18 years of age.
The Subject Expert Committee (SEC) for Covid-19 drugs under Central Drugs Control Standard Organisation (CDSCO) earlier recommended the Covaxin in two-dose regimen to be given at a gap of 28 days as primer and booster shots, sources told UNI. (UNI)
Covaxin will be the first Covid-19 vaccine in the country to be administered to those below 18 years of age.
The Subject Expert Committee (SEC) for Covid-19 drugs under Central Drugs Control Standard Organisation (CDSCO) earlier recommended the Covaxin in two-dose regimen to be given at a gap of 28 days as primer and booster shots, sources told UNI. (UNI)
